Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 Next >
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Novo Nordisk A/S Obesity US: News
From CNBC.com News
Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds
Tickers NEWS
Tags Markets Top Stories cannabis seniors
From Benzinga
Shark Tank's Barbara Corcoran Reveals Her Struggle With Alzheimer's In Her Family
Tickers NEWS
Tags Alzheimer's disease News Psychology
From Benzinga
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Business Biogen Inc Health care industry
From CNBC.com News
Midsummer News Flashes – Good and Not So Good
Tags Alzheimer's Disease tattoo Doc Gumshoe
From Stock Gumshoe
Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update
Tags coronavirus Alzheimer's Disease Doc Gumshoe
From Stock Gumshoe
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
Tickers ALS NEWS WENA
Tags General News Pre/Market Outlook
From Benzinga
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Tickers LLY NEWS
Tags Health Care General US Food and Drug Administration
From Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Electric vehicles Daily Open Tesla Inc
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Eli Lilly and Co Tesla Inc Daily Open
From CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
Tags cannabinoid Expert Ideas Top Stories
From Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
Tags Dementia Personal Finance Health insurance
From CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags Benzinga pharmaceuticals Stories That Matter
From Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
Tickers CBD
Tags Health Care General CBD
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Tickers ACIU BIIB ESAIY ESALY
Tags Health Care Biotech Small Cap
From Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
Tags Health Tips and Wellness Advice Alzheimer's disease Make It / Life
From CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
Tickers TECH
Tags machine learning Entrepreneurship Nature's Scientific Reports
From Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
Tags Make It / Success Science Podcasting
From CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
Tickers POTX TOKE
Tags Commodities General News
From Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
Tags Personal finance Elder care Alzheimer's disease
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Companies Breaking news Health care industry
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Breaking News: Business Business News Science
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Pharmaceuticals Law and Regulation Health & Science
From CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
Tickers ALZN BIIB LLY SAVA
Tags alzheimer's treatment General Top Stories
From Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Health care industry Business Biogen Inc
From CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
Tags Amprion Pfizer (PFE) Respiratory Synctial Virus (RSV)
From Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
Tags Benzinga Financing Alleh Lindquist
From Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US Economy Social issues US: News
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
Tags U/S/ Economy Politics Policy
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Breaking News: Business Eisai Co Ltd Business News
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.